Catalyst Pharmaceuticals (CPRX) Inventory Average (2019 - 2026)
Catalyst Pharmaceuticals' (CPRX) quarterly Inventory Average came in at $36.0 million in Q1 2026, up 83.36% YoY from $19.7 million in Q1 2025, and up 10.59% on a QoQ basis from $32.6 million in Q4 2025.
Catalyst Pharmaceuticals (CPRX) Inventory Average (2019 - 2026) Analysis & Trends
Catalyst Pharmaceuticals (CPRX) has 8 years of Inventory Average data on file, last reported at $36.0 million in Q1 2026.
- Quarterly Inventory Average rose 83.36% year-over-year to $36.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $36.0 million (up 83.36% YoY) and the FY2025 annual result came in at $28.4 million, up 61.17% from the prior year.
- Inventory Average climbed to $36.0 million in Q1 2026, from $32.6 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $36.0 million in Q1 2026 to a low of $7.0 million in Q4 2022.
- A 5-year average of $16.3 million and a median of $17.8 million in 2024 frame the typical range for Inventory Average.
- Annual changes were most pronounced in 2022 — Inventory Average declined 5.96% — and 2024, when it soared 107.77%.
- Tracing CPRX's Inventory Average over 5 years: stood at $7.0 million in 2022, then jumped by 77.08% to $12.3 million in 2023, then soared by 60.29% to $19.8 million in 2024, then soared by 64.81% to $32.6 million in 2025, then rose by 10.59% to $36.0 million in 2026.
- The last three Inventory Average figures came in at $36.0 million (Q1 2026), $32.6 million (Q4 2025), and $23.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 707.10 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 355,998.06 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 90.57 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 3.09 Bn | 134.92 Mn | 36.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.05 Mn |
| Dec 31, 2025 | 32.60 Mn |
| Sep 30, 2025 | 23.34 Mn |
| Jun 30, 2025 | 19.21 Mn |
| Mar 31, 2025 | 19.66 Mn |
| Dec 31, 2024 | 19.78 Mn |
| Sep 30, 2024 | 19.02 Mn |
| Jun 30, 2024 | 18.98 Mn |
| Mar 31, 2024 | 17.80 Mn |
| Dec 31, 2023 | 12.34 Mn |
| Sep 30, 2023 | 9.89 Mn |
| Jun 30, 2023 | 10.54 Mn |
| Mar 31, 2023 | 8.57 Mn |
| Dec 31, 2022 | 6.97 Mn |
| Sep 30, 2022 | 7.49 Mn |
| Jun 30, 2022 | 7.84 Mn |
| Mar 31, 2022 | 7.85 Mn |
| Dec 31, 2021 | 7.41 Mn |
| Sep 30, 2021 | 7.02 Mn |
| Jun 30, 2021 | 5.74 Mn |